ATI-50002

ATI-50002 · Aclaris Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ATI-50002, covering 2020-06-05 to 2020-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT) [Phase 2]

See pricing